Technical Analysis for PARNF - Parnell Pharmaceuticals Holdings Ltd.

Grade Last Price % Change Price Change
D 0.002 0.00% 0.0000
PARNF closed unchanged on Tuesday, May 17, 2022, on 1.39 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 100.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Parnell Pharmaceuticals Holdings Ltd. Description

Parnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Industry Pharmaceutical Products Pharmacy Pharmacology Arthritis Nutraceutical Software Platform Hormone Osteoarthritis Companion Nutraceutical Product Manufacturing Operations Dax Health Solutions Software Platforms Steroid Veterinary Pharmaceutical Treatment Of Osteoarthritis

Is PARNF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.89
52 Week Low 0.0001
Average Volume 7,188
200-Day Moving Average 0.2525
50-Day Moving Average 0.1360
20-Day Moving Average 0.0283
10-Day Moving Average 0.0006
Average True Range 0.0142
RSI 32.89
ADX 12.67
+DI 37.8811
-DI 43.4283
Chandelier Exit (Long, 3 ATRs) 0.1573
Chandelier Exit (Short, 3 ATRs) 0.0427
Upper Bollinger Bands 0.1141
Lower Bollinger Band -0.0575
Percent B (%b) 0.35
BandWidth 606.3604
MACD Line -0.0409
MACD Signal Line -0.0465
MACD Histogram 0.0056
Fundamentals Value
Market Cap 36.29 Thousand
Num Shares 18.1 Million
EPS -1.05
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.27
Price-to-Book 0.00
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0020
Resistance 3 (R3) 0.0020 0.0020 0.0020
Resistance 2 (R2) 0.0020 0.0020 0.0020 0.0020
Resistance 1 (R1) 0.0020 0.0020 0.0020 0.0020 0.0020
Pivot Point 0.0020 0.0020 0.0020 0.0020 0.0020
Support 1 (S1) 0.0020 0.0020 0.0020 0.0020 0.0020
Support 2 (S2) 0.0020 0.0020 0.0020 0.0020
Support 3 (S3) 0.0020 0.0020 0.0020
Support 4 (S4) 0.0020